AstraZeneca, after years of delays, opens UK hub meant to recharge drug research
Bio Pharma Dive
NOVEMBER 23, 2021
Formally unveiled five years after originally planned, the $1 billion headquarters will become the British drugmaker's second-largest R&D center by headcount.
Let's personalize your content